Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206374 · ClinicalTrials.gov registry record
Questionnaire and Laboratory Data on Vitiligo Vulgaris
A clinical trial, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT01206374: Completed study, sponsored by St. Luke's-Roosevelt Hospital Center.
NCT01206374 is a clinical trial that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01206374 has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Primary Outcome
dermatology life quality indices were you used and correlated with location of disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-08 |
| Est. Completion | 2014-09 |
What the finished NCT01206374 record still lists
NCT01206374 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01206374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01206374 about?
NCT01206374 is a clinical study titled "Questionnaire and Laboratory Data on Vitiligo Vulgaris". Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for d...
What is the current status of trial NCT01206374?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2010-08. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01206374?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia